GW plans cannabis offshoots
GW plans cannabis offshoots
Sativex, launched in the UK in June, is the only cannabis-based
medicine to receive approval from medical authorities for use as a
prescription drug, and has been the driving force behind Aim-traded GW.
However, Justin Gover, managing director, ...